Glucuronidation Pathways of 5- and 7-Hydroxypropranolol: Determination of Glucuronide Structures and Enzyme Selectivity
Propranolol, a non-selective beta-blocker medication, has been utilized in the treatment of cardiovascular diseases for several decades. Its hydroxynaphthyl metabolites have been recognized to possess varying degrees of beta-blocker activity due to the unaltered side-chain. This study achieved the s...
Main Authors: | Fan Yang, Maxi Wenzel, Matthias Bureik, Maria Kristina Parr |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/23/7783 |
Similar Items
-
Complete Reaction Phenotyping of Propranolol and 4-Hydroxypropranolol with the 19 Enzymes of the Human UGT1 and UGT2 Families
by: Fan Yang, et al.
Published: (2022-07-01) -
Dysregulated hepatic UDP-glucuronosyltransferases and flavonoids glucuronidation in experimental colitis
by: Wanying Zeng, et al.
Published: (2022-11-01) -
Identification of Bromophenols' glucuronidation and its induction on UDP- glucuronosyltransferases isoforms
by: Haoqian Zhang, et al.
Published: (2024-05-01) -
Identification of Human UDP-Glucuronosyltransferase Involved in Gypensapogenin C Glucuronidation and Species Differences
by: Juan Chen, et al.
Published: (2023-01-01) -
The Use of Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide Excretion Rates to Navigate the Continuum of Ovarian Activity
by: Leonard F. Blackwell, et al.
Published: (2018-05-01)